Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome
Ruth Tuomala(Brigham and Women's Hospital), Marc Bulterys(World Health Organization), Michael J. O’Sullivan, Michael Hughes(AIDS Clinical Trials Group), David E. Shapiro(Intercept Pharmaceuticals (United States)), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Mary Culnane(National Institute of Allergy and Infectious Diseases), Yvonne J. Bryson(Oklahoma State University Center for Health Sciences)
Cited by 347
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k